Ownership history in HM PAYSON & CO · 25 quarters on record
This page tracks every 13F SEC filing in which HM PAYSON & CO reported a position in IMMUCELL CORP (ICCC). Data includes quarterly share count, position size as % of portfolio, estimated market value, and end-of-quarter stock price — sourced directly from SEC EDGAR 13F filings.
| Quarter | Action | Shares | Change | Chg % | % of Fund | Mkt Value | Price (EOQ) |
|---|---|---|---|---|---|---|---|
| 2025 Q4 | UNCHANGED | 4,000 | — | 0% | 0.00% | $25K | $6.15 |
| 2025 Q3 | UNCHANGED | 4,000 | — | 0% | 0.00% | $26K | $6.25 |
| 2025 Q1 | UNCHANGED | 4,000 | — | 0% | 0.00% | $19K | $4.79 |
| 2024 Q4 | UNCHANGED | 4,000 | — | 0% | 0.00% | $21K | $5.15 |
| 2024 Q3 | REDUCED | 4,000 | -2,000 | -33.3% | 0.00% | $15K | $3.63 |
| 2024 Q2 | UNCHANGED | 6,000 | — | 0% | 0.00% | $29K | $4.85 |
| 2024 Q1 | UNCHANGED | 6,000 | — | 0% | 0.00% | $32K | $5.30 |
| 2023 Q4 | UNCHANGED | 6,000 | — | 0% | 0.00% | $30K | $5.09 |
| 2023 Q3 | REDUCED | 6,000 | -6,130 | -50.5% | 0.00% | $31K | $5.34 |
| 2023 Q2 | ADDED | 12,130 | +4,000 | +49.2% | 0.00% | $62K | $5.00 |
As of 2025 Q4 — sorted by position size